Methodology Pricing

Regeneron Pharmaceuticals, Inc.

REGN

HealthcareBiotechnologyNASDAQ

$760.54

Market Cap: $79.02B

Valuation Financials Forecast Compare Historical Price Solvency Dividends Transactions People

SweetValueLab © 2026

Methodology Pricing About

Not financial advice. Data may be delayed.

Valuation Summary Discounted Cash Flow Trading Multiples PEG Fair Value Earnings Power Value Analyst Estimates Dividend Discount ModelSoon WACC

Similar Stocks to REGN

Coming soon